Back
Day Range
$186.01
$191.50
52-Week Range
$171.00
$242.80
Volume
4,190,345
50D / 200D Avg
$214.85
/
$210.29
Prev Close
$190.00
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 37.2 | 0.4 |
| P/B | 2.6 | 2.9 |
| ROE % | 7.1 | 3.9 |
| Net Margin % | 14.7 | 3.8 |
| Rev Growth 5Y % | -4.4 | 10.0 |
| D/E | 0.4 | 0.2 |
Analyst Price Target
Hold
$253.75
+33.5%
Low: $220.00
High: $270.00
Forward P/E
22.59
Forward EPS
$8.41
EPS Growth (est.)
+0.0%
Est. Revenue
25.62B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.82
$11.61 – $12.71
|
31.96B | 2 |
| FY2029 |
$10.88
$10.69 – $11.70
|
30.50B | 2 |
| FY2028 |
$10.01
$8.82 – $11.73
|
28.84B | 4 |
No quarterly estimates available
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 |
McGrew Matthew
Executive Vice President
|
grant | 21,974 | — | — |
| Feb 24, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 189 | $209.19 | $39,536.91 |
| Feb 24, 2026 |
Gutierrez-Ramos Jose-Carlos
SVP, Chief Science Officer
|
other | 344 | $209.19 | $71,961.36 |
| Feb 24, 2026 |
Bouda Christopher
VP, Chief Accounting Officer
|
other | 235 | $209.19 | $49,159.65 |
| Feb 24, 2026 |
Sawyer Montgomery Julie A
Executive Vice President
|
other | 372 | $209.19 | $77,818.68 |
| Feb 24, 2026 |
Couchara Georgeann
SVP, Human Resources
|
other | 101 | $209.19 | $21,128.19 |
| Feb 24, 2026 |
Riley Christopher Paul
Executive Vice President
|
other | 242 | $209.19 | $50,623.98 |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 2,640 | $58.59 | — |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
sell | 1,320 | $208.01 | $274,574.52 |
| Feb 4, 2026 |
Blair Rainer
President & CEO
|
grant | 8,474 | — | — |
| Jan 30, 2026 |
List Teri
Director
|
grant | 11 | $218.89 | $2,407.79 |
| Jan 30, 2026 |
Sanders A Shane
Director
|
grant | 184 | $218.89 | $40,275.76 |
| Nov 15, 2025 |
GRAY R BRADLEY
SVP Strategic Development
|
other | 1,402 | $221.21 | $310,136.42 |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 8,352 | $88.24 | — |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
sell | 5,174 | $210.44 | $1,088,703.65 |
| Jul 15, 2025 |
Zerhouni Elias A.
Director
|
other | 9,065 | $59.34 | — |
| Jul 2, 2025 |
List Teri
Director
|
other | 9,006 | $59.34 | — |
| May 15, 2025 |
Blair Rainer
President & CEO
|
other | 27,490 | — | — |
| May 15, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 281 | $190.95 | $53,656.95 |
| May 15, 2025 |
Zerhouni Elias A.
Director
|
grant | 2,055 | — | — |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -4.43% annually over 5 years
Debt/Equity of 0.35 — conservative balance sheet
Generating 5.26B in free cash flow
P/E of 37.20 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.33%
Cash machine — converts 145.55% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-4.43%
Revenue (1Y)2.90%
Earnings (1Y)-7.31%
FCF Growth (3Y)-4.61%
Quality
Return on Equity
7.08%
ROIC5.43%
Net Margin14.71%
Op. Margin20.91%
Safety
Debt / Equity
0.35
Current Ratio1.87
Interest Coverage19.38
Valuation
P/E Ratio
37.20
Forward P/EN/A
P/B Ratio2.56
EV/EBITDA28.86
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.90% | Revenue Growth (3Y) | 1.41% |
| Earnings Growth (1Y) | -7.31% | Earnings Growth (3Y) | -12.90% |
| Revenue Growth (5Y) | -4.43% | Earnings Growth (5Y) | -13.42% |
| Profitability | |||
| Revenue (TTM) | 24.57B | Net Income (TTM) | 3.61B |
| ROE | 7.08% | ROA | 4.33% |
| Gross Margin | 60.93% | Operating Margin | 20.91% |
| Net Margin | 14.71% | Free Cash Flow (TTM) | 5.26B |
| ROIC | 5.43% | FCF Growth (3Y) | -4.61% |
| Safety | |||
| Debt / Equity | 0.35 | Current Ratio | 1.87 |
| Interest Coverage | 19.38 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 37.20 | Forward P/E | N/A |
| P/B Ratio | 2.56 | P/S Ratio | 5.47 |
| PEG Ratio | -9.18 | Forward PEG | N/A |
| EV/EBITDA | 28.86 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3.91% | ||
| Market Cap | 134.43B | Enterprise Value | 148.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24.57B | 23.88B | 23.89B | 26.64B | 29.45B |
| Net Income | 3.61B | 3.90B | 4.76B | 7.21B | 6.43B |
| EPS (Diluted) | 5.04 | 5.29 | 6.38 | 9.64 | 8.61 |
| Gross Profit | 14.97B | 14.21B | 14.03B | 16.19B | 17.95B |
| Operating Income | 5.14B | 5.18B | 5.28B | 7.54B | 8.05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 83.46B | 77.54B | 84.49B | 84.35B | 83.18B |
| Total Liabilities | 30.93B | 27.99B | 31.00B | 34.26B | 38.01B |
| Shareholders' Equity | 52.53B | 49.54B | 53.49B | 50.08B | 45.17B |
| Total Debt | 18.42B | 17.15B | 19.54B | 20.62B | 23.27B |
| Cash & Equivalents | 4.62B | 2.08B | 5.86B | 6.00B | 2.59B |
| Current Assets | 12.76B | 9.50B | 13.94B | 15.88B | 11.65B |
| Current Liabilities | 6.81B | 6.80B | 8.27B | 8.39B | 8.14B |